Regulation of transgene expression using an inducible system for improved safety of intervertebral disc gene therapy

Spine

Volumn 32, Issue 13, 2007, Pages 1381-1387

  Vadalà, Gianluca ^a,b   Sowa, Gwendolyn A ^a   Smith, Lauren ^a   Hubert, Mark G ^a   Levicoff, Eric A ^a   Denaro, Vincenzo ^b   Gilbertson, Lars G ^a   Kang, James D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Gene therapy; Inducible system; Intervertebral disc degeneration; Nucleus pulposus cells; Safety

Indexed keywords

ADENOVIRUS VECTOR; FAS LIGAND; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TETRACYCLINE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; INTERVERTEBRAL DISK; NUCLEUS PULPOSUS; PRIORITY JOURNAL; TRANSGENE;

ADENOVIRIDAE; CELLS, CULTURED; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; INTERVERTEBRAL DISK; PLASMIDS; TETRACYCLINE; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 34249908639     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3180601215     Document Type: Article

References (35)

1. Zhang Y, Li Z, Thonar EJ, et al. Transduced bovine articular chondrocytes affect the metabolism of cocultured nucleus pulposus cells in vitro: implications for chondrocyte transplantation into the intervertebral disc. Spine 2005;30:2601-7.
2. Nishida K, Kang JD, Gilbertson LG, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 1999;24:2419-25.
3. Wallach CJ, Sobajima S, Watanabe Y, et al. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 2003;28:2331-7.
4. Paul R, Haydon RC, Cheng H, et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003;28:755-63.
5. Yoon ST, Park JS, Kim KS, et al. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 2004;29:2603-11.
6. Shimer AL, Sobajima S, Chadderdon RC, et al. BMP-2 gene transfer favorably alters course of disc degeneration in rabbit model. Orthopaedic Research Society, Washington, DC, 2005:183.
7. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-5.
8. Wallach CJ, Kim JS, Sobajima S, et al. Safety assessment of intradiscal gene transfer: a pilot study. Spine J 2006;6:107-12.
9. Kim JS, Sobajima S, Wallach CJ, et al. A profile of safety: the potential hazards of intradiscal gene therapy. Orthopaedic Research Society, Washington, DC, 2005:37.
10. Lattermann C, Oxner WM, Xiao X, et al. The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and preexposed rabbits. Spine 2005;30:497-504.
11. Favre D, Provost N, Blouin V, et al. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol Ther 2001;4:559-66.
12. Tal J. Adeno-associated virus-based vectors in gene therapy. J Biomed Sci 2000;7:279-91.
13. Yarranton GT. Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 1992;3:506-11.
14. Schweinfest CW, Graber MW, Henderson KW, et al. Cloning and sequence analysis of Hsp89alpha DeltaN, a new member of theHsp90 gene family. Biochim Biophys Acta 1998;1398:18-24.
15. Hu MC, Davidson N. A combination of derepression of the lac operatorrepressor system with positive induction by glucocorticoid and metal ions provides a high-level-inducible gene expression system based on the human metallothionein-IIA promoter. Mol Cell Biol 1990;10:6141-51.
16. Ko MS, Takahashi N, Sugiyama N, et al. An auto-inducible vector conferring high glucocorticoid inducibility upon stable transformant cells. Gene 1989;84:383-9.
17. Corbel SY, Rossi FM. Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes. Curr Opin Biotechnol 2002;13:448-52.
18. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992;89:5547-51.
19. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-9.
20. Chelberg MK, Banks GM, Geiger DF, et al. Identification of heterogeneous cell populations in normal human intervertebral disc. J Anat 1995;186 (Pt 1):43-53.
21. Rubinchik S, Ding R, Qiu AJ, et al. Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system. Gene Ther 2000;7:875-85.
22. Ralph GS, Bienemann A, Harding TC, et al. Targeting of tetracyclineregulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors. Neuroreport 2000;11:2051-5.
23. Ning SB, Zhang ZB, Xie WF, et al. Construction of a recombinant adenovirus carrying endothelial nitric oxide synthase gene and its expression and control in esophageal smooth muscle cells. Chin J Dig Dis 2004;5:17-21.
24. Harding TC, Geddes BJ, Murphy D, et al. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotechnol 1998;16:553-5.
25. Meyer-Ficca ML, Meyer RG, Kaiser H, et al. Comparative analysis of inducible expression systems in transient transfection studies. Anal Biochem 2004;334:9-19.
26. Alp E, Koc RK, Durak AC, et al. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC Infect Dis 2006;6:72.
27. Nas K, Gur A, Kemaloglu MS, et al. Management of spinal brucellosis and outcome of rehabilitation. Spinal Cord 2001;39:223-7.
28. Vaverka M, Petrzelova J. Penetration of antibiotics into the intervertebral disk. Acta Chir Orthop Traumatol Cech 1991;58:98-103.
29. Graham LD. Ecdysone-controlled expression of transgenes. Expert Opin Biol Ther 2002;2:525-35.
30. Karzenowski D, Potter DW, Padidam M. Inducible control of transgene expression with ecdysone receptor: gene switches with high sensitivity, robust expression, and reduced size. Biotechniques 2005;39:191- 6.
31. Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-2.
32. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
33. Park JB, Chang H, Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine 2001;26:618-21.
34. Takada T, Nishida K, Doita M, et al. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine 2002;27:1526-30.
35. Kaneyama S, Nishida K, Dolta M, et al. How Fas ligand expression on the disc cell changes with degeneration of intervertebral disc. International Society of the Study of the Lumbar Spine, Bergen, Norway, 2006:103.